Andelen af patienter med HIV RNA < 400 kopier/ ml i REYATAZ + ritonavir- armen og lopinavir + ritonavir- armen var henholdsvis 53% 54% ved ITT- analyse (intent- to- treat), hvor manglende værdier betragtedes som manglende effekt.
The proportions of patients with HIV RNA < 400 copies/ ml in the REYATAZ + ritonavir arm and the lopinavir + ritonavir arm were 53% and 54%, respectively, by intent-to-treat analysis, with missing values considered as failures.